The Safety and Effectiveness of 524W91
NCT00002335 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18
Last updated 2005-06-24
Summary
To assess the safety and pharmacokinetics of single oral doses of 524W91 administered in HIV-infected patients. To determine the effects of food on bioavailability of 524W91.
Conditions
- HIV Infections
Interventions
- DRUG
Sponsors & Collaborators
-
Glaxo Wellcome
lead INDUSTRY
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
A Multicenter Placebo-Controlled Dose Titration Study to Evaluate the Efficacy and Safety of Sandostatin (SMS 201-995) in the Treatment of Patients With Acquired Immunodeficiency Related Diarrhea
NCT00002252 ·Status: COMPLETED ·Phase: NA
-
Treatment of Patients With Human Immunodeficiency Virus (HIV)-Related Chronic Diarrhea With Saccharomyces Boulardii or Placebo: A Double Blind Trial
NCT00002088 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of MDL 28,574A in HIV-Infected Patients
NCT00002329 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes
NCT00002293 ·Status: COMPLETED ·Phase: NA
-
Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)
NCT00000765 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease
NCT00002244 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Acceptability/Swallowability of DRV-Containing FDC Tablets in HIV-1 Infected Adolescents, Using Matching Placebo Tablets
NCT02993237 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Peldesine (BCX-34) in HIV-Infected Patients
NCT00002237 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose-Escalating Study of Ro 31-8959 ( HIV Protease Inhibitor ) in Patients With HIV Disease.
NCT00002111 ·Status: COMPLETED ·Phase: PHASE1
-
Phase IIa Dose-ranging Study of GSK1349572 in HIV-1 Infected Adults
NCT00708110 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 2 Study Of PF-00232798 In HIV Positive Patients
NCT00495677 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of Z-100 in Patients With Early HIV Infection
NCT00016692 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of an Oral Entry Inhibitor, SP01A, in Treatment-Experienced HIV-Infected Patients
NCT00113412 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Lobucavir in Patients With AIDS
NCT00002352 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of 3 Doses of Crofelemer Compared to Placebo in the Treatment of HIV Associated Diarrhea
NCT00547898 ·Status: COMPLETED ·Phase: PHASE3
-
A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis
NCT00002191 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Effectiveness of Megace in HIV-Infected Women
NCT00002345 ·Status: COMPLETED ·Phase: PHASE4
-
A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection
NCT00000823 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Zidovudine in the Treatment of HIV-Infected Children With Mild to Moderate Symptoms
NCT00000990 ·Status: COMPLETED ·Phase: PHASE2
-
Placebo-Controlled Trial of Safety and Efficacy of Thalidomide in Patients With Infections Due to Mycobacterium and/or HIV
NCT00002104 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, PK and PD Study of ABX464 in Untreated HIV Patients
NCT02452242 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC
NCT00000999 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection
NCT00000812 ·Status: COMPLETED ·Phase: PHASE1
-
SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients
NCT00299897 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus
NCT00361101 ·Status: COMPLETED ·Phase: PHASE1